2008
DOI: 10.1016/j.revmed.2008.01.029
|View full text |Cite
|
Sign up to set email alerts
|

Vers un diagnostic biologique de la maladie d’Alzheimer et des syndromes apparentés

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2009
2009
2012
2012

Publication Types

Select...
3

Relationship

0
3

Authors

Journals

citations
Cited by 3 publications
(1 citation statement)
references
References 121 publications
0
1
0
Order By: Relevance
“…Their presence is difficult to monitor, specifically in different body fluids like blood and cerebrospinal fluid (CSF) 2, 3. Standard immunoenzymatic tests are not sensitive enough to give reliable identification in the ante mortem stage due to the extremely low concentrations of these proteins 4–7. Moreover, Perret‐Liaudet et al8 noticed a great loss of phosphorylated Tau protein (pTau181), Tau, and Aβ‐42 peptide on the inner walls of sampling tubes with time, leading to false titration values.…”
Section: Introductionmentioning
confidence: 99%
“…Their presence is difficult to monitor, specifically in different body fluids like blood and cerebrospinal fluid (CSF) 2, 3. Standard immunoenzymatic tests are not sensitive enough to give reliable identification in the ante mortem stage due to the extremely low concentrations of these proteins 4–7. Moreover, Perret‐Liaudet et al8 noticed a great loss of phosphorylated Tau protein (pTau181), Tau, and Aβ‐42 peptide on the inner walls of sampling tubes with time, leading to false titration values.…”
Section: Introductionmentioning
confidence: 99%